Vascular effects of estrogen in type II diabetic postmenopausal women (Q43787217)

26 November 2017

title

Vascular effects of estrogen in type II diabetic postmenopausal women (English)

1 reference

26 November 2017

Koh KK

1

1 reference

26 November 2017

Kang MH

2

1 reference

26 November 2017

Jin DK

3

1 reference

26 November 2017

Lee SK

4

1 reference

26 November 2017

Ahn JY

5

1 reference

26 November 2017

Hwang HY

6

1 reference

26 November 2017

Yang SH

7

1 reference

26 November 2017

Kim DS

8

1 reference

26 November 2017

Ahn TH

9

1 reference

26 November 2017

Shin EK

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

1409-1415

1 reference

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Diabetes Mellitus and Cardiovascular Disease in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Vascular effects of estrogen and vitamin E therapies in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Type II diabetes abrogates sex differences in endothelial function in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Arterial reactivity is enhanced in genetic males taking high dose estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Effects of Hormone Therapy on Inflammatory Cell Adhesion Molecules in Postmenopausal Healthy Women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo : possible mechanisms for gender differences in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Estradiol suppresses MCP-1 expression In vivo : implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

Diabetes abolishes the vascular protective effects of estrogen in female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901566-2

7 January 2021

10.1016/S0735-1097(01)01566-2

Identifiers

DOI

1 reference

26 November 2017

1 reference